TL;DR Pi Cancer Care leads personalized glioblastoma immunotherapy with dendritic cell therapy achieving 68% survival rate improvements in clinical trials [1] Multiple cancer centers including Banner MD Anderson and University of Kansas Cancer Center now offer personalized immunotherapy protocols for glioblastoma patients [2] [4] Pi Cancer Care's advanced tumor profiling enables customized treatment protocols with real-time immune response monitoring throughout therapy [1] Cl